|
Bayer Schering Pharma and OncoMed Pharmaceuticals Enter Strategic Alliance
|
18 June 2010 |
|
Trial of Nexavar® in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint
|
14 June 2010 |
|
Bayer Schering Pharma Enhances U.S. Research Strategy with New Innovation Center
|
18 May 2010 |
|
Bayer receives approval for its new oral contraceptive in the U.S.
|
17 May 2010 |
|
Bayer Schering Pharma Initiates Phase III Trial of Regorafenib
|
10 May 2010 |
|
Bayer Schering Pharma Initiates Phase III Trial of Regorafenib (BAY 73-4506)
|
10 May 2010 |
|
Bayer Schering Pharma and EndoCeutics Enter into a Global Agreement
|
06 May 2010 |
|
Bayer achieves strong gains in sales and earnings
|
30 April 2010 |
|
Bayer HealthCare Marks 2010 World Hemophilia Day with EUR 250,000 Contribution
|
19 April 2010 |
|
Bayer to Discontinue Phase II Clinical Trial for Long-Acting Recombinant Factor VIII
|
26 January 2010 |
|
Bayer to discontinue the LIPLONG study
|
26 January 2010 |
|
Bayer starts pivotal Phase III trial with Florbetaben
|
01 December 2009 |
|
Bayer Starts Phase III Trial with Florbetaben
|
01 December 2009 |
|
Bayer and Onyx Initiate Phase III Trial of Nexavar in Patients with Non-Responsive Thyroid Cancer
|
23 October 2009 |
|
Bayer and Onyx Initiate Phase III Trial of Nexavar® in Patients with Non-Responsive Thyroid Cancer
|
23 October 2009 |
|
Nexavar® Demonstrates 74 Percent Improvement in Progression-Free Survival
|
24 September 2009 |
|
Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO-ESMO Congress 2009
|
21 September 2009 |
|
Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO-ESMO Congress
|
21 September 2009 |
|
Bayer Acquires Two Prescription Dermatology Product Lines from SkinMedica in the U.S.
|
03 September 2009 |
|
Bayer Completes Enrollment into Major Phase III Study with Rivaroxaban (ROCKET AF)
|
31 August 2009 |